Cardiol Therapeutics - Bargain Stock Price And Share Price Appreciation Catalysts
Cardiol Therapeutics (CRDL)(CRDL.CA) is a pioneer in CBD-based treatment for heart disease. The company's lead drug, CardiolRx™, is undergoing clinical trials for treating Recurring Pericarditis and Acute Myocarditis. CardioRx is a THC-free (<10 ppm) pharmaceutically produced ultra-pure, high-concentration cannabidiol oral formulation that is manufactur…
Keep reading with a 7-day free trial
Subscribe to Microcap Opportunities to keep reading this post and get 7 days of free access to the full post archives.